German site
Partnering to bring more medicines to patients
Pharmanovia is a trusted partner of choice with biotech companies, large pharamaceutical companies and CSOs and CDMOs. We have a strong track record bringing products to market at all stages of a product’s life cycle from new chemical entities right through to established brands.
We combine specialty pharmaceutical focus with medical, regulatory, market access, supply chain and commercial expertise to shape the right approach and deliver in a way that is commercially sound and patient-centred.
Our focus
We focus on launching and commercialising specialty pharma in Europe, Middle East and Africa (EMEA) either through in-licensing or acquisition. We have a long track record and the expertise and execution needed to support innovative medicines and create long-term value through partnership. Alongside our specialty focus, we continue to support established medicines trusted by patients and healthcare professionals around the world.
Experienced partner of choice
How we can work together
“We build meaningful relationships that drive long term value for partners, healthcare systems and ultimately deliver for patients.”
Peter Hames
Chief Corporate Development Officer
Why partners choose us:
- Successful launch track record across specialty and established brands
- More than 30 asset transactions and in-licensing deals successfuly completed including 6 NCEs
- Global commercialisation capabilities
- Market assessment and launch planning
- Transparent collaboration and accountable delivery
- Disciplined BD, licensing and M&A frameworks and fast decision making
What we offer:
- Access to over 160 markets worldwide
- Local in-market presence in core markets
- End-to-end capabilities from regulatory to commercial
- EMEA specialty launch experience
- Establish brands expertise in complex markets
- Partnership models tailored to commercial goals
Where we're looking to partner
Corporate partnerships
We work with developers, innovative and specialty pharma, biotech and large-cap pharma to license and acquire products that that meet patient need. We are therapy area agnostic but look for clear synergies with our portfolio and pipeline.
Distribution
We work with Third-Party Logistics (3PLs) businesses as well as local specialist distributors and Contract Sales Organisations (CSOs) to distribute, market and promote our products throughout the world.
Manufacturing
We work with Contract Manufacturing Organisations (CMOs) for the manufacturing of Active Pharmaceutical Ingredient (API), tolling and packing.
Global reach, local expertise
- Our markets
- Our headquarters
- Our offices
Partnership news
Pharmanovia acquires exclusive rights to novel antipsychotic treatment
BASILDON, UK, 1st April 2025 Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises,...
More informationPharmanovia announces exclusive distribution agreement with Er-Kim for Sunosi® in Eastern Europe
PRESS RELEASE – FOR TRADE AND BUSINESS MEDIA ONLY Basildon, UK – 21 February 2025 Pharmanovia,...
More informationPharmanovia signs in-licensing deal for novel osteoporosis treatment with Radius Health
BASILDON, UK, 02 January 2025 Pharmanovia, a global pharmaceutical company that commercialises novel medicines and revitalises,...
More informationWant to partner with us? Get in touch
Corporate development: bd@pharmanovia.com
Manufacturing: supplychain@pharmanovia.com
Distribution: international@pharmanovia.com